Steven Girgenti Bio Affinity Technologies, Inc. (BIAF) insider trading activity

Steven Girgenti is Executive Chairman of bioAffinity Technologies, Inc.. Currently has a direct ownership of 1.08 Million shares of BIAF, which is worth approximately $820,847. The most recent transaction as insider was on Jan 10, 2025, when has been sold 14,814 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.08M

1.39% 3M change

13.42% 12M change

Total Value Held $820,847

STEVEN GIRGENTI Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 10 2025	BUY Grant, award, or other acquisition	-	14,814 Added 1.35%	1,080,062 Common Stock
Jul 01 2024	BUY Grant, award, or other acquisition	-	33,784 Added 3.07%	1,065,248 Common Stock
Jun 12 2024	BUY Grant, award, or other acquisition	-	8,296 Added 0.8%	1,031,464 Common Stock
Apr 03 2024	SELL Payment of exercise price or tax liability	$74,901 $2.24 p/Share	33,438 Reduced 3.16%	1,023,168 Common Stock
Apr 03 2024	BUY Exercise of conversion of derivative security	$75,223 $1.16 p/Share	64,848 Added 5.78%	1,056,606 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	$60,000 $1.52 p/Share	39,474 Added 3.83%	991,758 Common Stock
Jan 31 2024	BUY Grant, award, or other acquisition	-	11,943 Added 1.24%	952,284 Common Stock
Jan 01 2024	BUY Grant, award, or other acquisition	$18,748 $1.48 p/Share	12,668 Added 1.33%	940,341 Common Stock
Oct 01 2023	BUY Grant, award, or other acquisition	$18,749 $1.58 p/Share	11,867 Added 1.26%	927,673 Common Stock
Aug 09 2023	BUY Grant, award, or other acquisition	$59,998 $2.28 p/Share	26,315 Added 2.79%	915,806 Common Stock
Jul 01 2023	BUY Grant, award, or other acquisition	$18,748 $1.83 p/Share	10,245 Added 1.14%	889,491 Common Stock
Jul 01 2023	BUY Grant, award, or other acquisition	$18,748 $1.83 p/Share	10,245 Added 1.14%	889,491 Common Stock
Apr 15 2023	BUY Grant, award, or other acquisition	$18,748 $1.89 p/Share	9,920 Added 1.12%	879,246 Common Stock
Apr 15 2023	BUY Grant, award, or other acquisition	$18,748 $1.89 p/Share	9,920 Added 1.12%	879,246 Common Stock
Jan 01 2023	BUY Grant, award, or other acquisition	$18,757 $2.28 p/Share	8,227 Added 0.94%	869,326 Common Stock
Jan 01 2023	BUY Grant, award, or other acquisition	$18,757 $2.28 p/Share	8,227 Added 0.94%	869,326 Common Stock
Sep 06 2022	BUY Conversion of derivative security	$2,369,255 $4.15 p/Share	570,905 Added 41.04%	820,183 Common Stock
Aug 31 2022	BUY Open market or private purchase	-	40,916 Added 4.54%	861,099 Common Stock

Also insider at

VYCO

VYCOR MEDICAL INC Healthcare

Director

Steven Girgenti

Executive Chairman

Newyork, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIAF shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Affinity Technologies, Inc. insider buys or sells BIAF shares.

Notify only if

Operation

Value

Type

News

Receive news related to bioAffinity Technologies, Inc.

Track Activities on BIAF

Account